✦ LIBER ✦

BRADYKININ INDUCED MITOGENESIS OF ANDROGEN INDEPENDENT PROSTATE CANCER CELLS

✍ Scribed by BARKI-HARRINGTON, LIZA; DAAKA, YEHIA

Book ID: 123352744
Publisher: Lippincott Williams and Wilkins
Year: 2001
Tongue: English
Weight: 522 KB
Volume: 165
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)66305-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MIR-125b INDUCES ANDROGEN-INDEPENDENT GR

MIR-125b INDUCES ANDROGEN-INDEPENDENT GROWTH OF PROSTATE CANCER CELLS

✍ Shi, Xu-Bao; Xue, Lingru; Yang, Joy; Evans, Christopher P; deVere White, Ralph W 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 135 KB

The bradykinin/soluble guanylate cyclase

The bradykinin/soluble guanylate cyclase signaling pathway is impaired in androgen-independent prostate cancer cells

✍ Zi-Jiang Chen; Michael Vetter; Danian Che; Shiguo Liu; Min-Lung Tsai; Chung-Ho C 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Camptothecin sensitizes androgen-indepen

Camptothecin sensitizes androgen-independent prostate cancer cells to anti-Fas-induced apoptosis

✍ Costa-Pereira, A P; Cotter, T G 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 564 KB

Stem Cell Genes in Androgen-independent

Stem Cell Genes in Androgen-independent Prostate Cancer

✍ Matthew Bui; Robert E. Reiter 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 97 KB

“Thymineless” death in androgen-independ

“Thymineless” death in androgen-independent prostatic cancer cells

✍ Natasha Kyprianou; John T. Isaacs 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 975 KB

ERK inhibitor PD98059 enhances docetaxel

ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells

✍ Stanislav Zelivianski; Matthew Spellman; Mark Kellerman; Vladimir Kakitelashvill 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 390 KB

## Abstract Anticancer drugs docetaxel and vinorelbine suppress cell growth by altering microtubule assembly and activating the proapoptotic signal pathway. Vinorelbine and docetaxel have been approved for treating several advanced cancers. However, their efficacy in the management of advanced horm